Financials
- Market Capitalization 2.46 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.32
ratio cours/chiffre d'affaires
-2 874.39
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1857 | PGEN Precigen, Inc. - Common Stock | 6.95 USD | -3.34% | -2.80% | +11.56% | +54.79% | 2.49 B USD | ||
| 1862 | NKTR Nektar Therapeutics - Common Stock | 72.52 USD | -2.72% | -0.67% | +2.55% | -1.02% | 2.48 B USD | ||
| 1880 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.79 USD | -6.51% | -4.60% | -8.40% | +134.83% | 2.39 B USD | ||
| 1885 | KOD Kodiak Sciences Inc - Common Stock | 37.72 USD | -3.58% | -2.05% | -9.28% | +326.21% | 2.37 B USD |